We recognise that our customers may be worried about the impact of COVID-19 and our ability to continue to provide services to partners. Read about our response.


Our latest news and announcements

CPI Printed Sensors Project Aims to Reduce Cost and Increase Efficiency of Electric Vehicle Batteries

CPI is involved in a collaborative project which aims to develop novel printed sensors for electric vehicle (EV) battery current density imaging.

Dec 04 2019

CPI’s Graham Hillier Receives Lifetime Achievement Award for Services to Innovation

Graham Hillier, CPI’s Director of Strategy and Futures, has received the lifetime achievement award at the North East Innovation Awards 2019.

Dec 04 2019

CPI Partners with University of Leeds to produce a New Polio Vaccine

CPI today announced a new project with multiple stakeholders to develop a low-cost, scalable manufacturing process for a new vaccine against poliovirus.

Dec 03 2019

Vaccine Development at CPI

The World’s population is facing increased threats of disease from pathogens. Whether it is an influenza pandemic or outbreak such as the recent Ebola crisis in Africa or diseases such as Malaria or Severe Acute Respiratory Syndrome (SARS), the need for cheaper, effective vaccines is on the rise. Thanks to advances in medicine, we can now use viruses to treat disease, and it’s this area of vaccine development where CPI can help.

Dec 02 2019

CPI welcomes Katie Murray to Medicines Manufacturing Innovation Centre team

CPI are delighted to welcome Katie Murray to the Medicines Manufacturing Innovation Centre team. Katie will join CPI on a 2 year secondment from AstraZeneca as Technology Director of the centre starting in early 2020. Katie will be responsible for leading the development and delivery of the technology strategy, she will work closely with the team to enable the development of scientific knowledge and practice within the centre.

Nov 28 2019

CPI partners with ImmunoBiology Ltd to manufacture heat-stabilised Pneumococcal vaccine formulation

CPI today announced a partnership with ImmunoBiology Ltd (ImmBio), Cambridge, to develop a heat-stabilised formulation for ImmBio’s multi-antigen vaccine candidate against Pneumococcal diseases. This will eliminate the requirement for a costly and complex cold chain, helping to reduce the cost of the vaccine and increase accessibility in LMICs (Low and Middle Income Countries) where cold chains may be lacking.

Nov 28 2019

Visiting PhD students get an insight into careers in formulation technology

CPI hosted group of first year PhD students who are part of the EPSRC funded Centre for Doctoral Training in Soft Matter for Formulation and Industrial Innovation. The students visited CPI’s Coxon Building at Netpark, Sedgefield to understand more about CPI and the innovation process, with a focus on science and technology relating to formulation and materials.

Nov 27 2019

CPI partners with MFC Foundation to deliver Meaningful Encounters’ community outreach programme

CPI has partnered with the MFC Foundation to deliver the Chris Dowle Meaningful Encounters’ programme for students at Thornaby Academy in Teesside. Launching in October, the programme will encourage and inspire young people in the North East to start considering their career options and professional development pathways available.

Nov 26 2019

CPI Announced as Winner of Biotechnology Award at IChemE Global Awards 2019 Event

CP has been announced as the winner of the Global Biotechnology Award at the prestigious Institution of Chemical Engineers (IChemE) Global Awards 2019.

Nov 18 2019
 Previous Next  
1 2 3 4 5 Next  

Page 3 of 59